Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Imiqimod in clinical practice.

K F Trofatter1

  • 1Mount Sinai Medical Center, Department of Obstetrics and Gynecology, 1 Mount Sinai Drive, Cleveland, Ohio, USA 44106-4198, USA.

European Journal of Dermatology : EJD
|July 1, 1999
PubMed
Summary

Imiquimod 5% cream effectively treats external genital and perianal warts by stimulating the immune system. This treatment shows lower recurrence rates compared to other therapies for human papilloma virus (HPV) infections.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Increased frequency of dosing of imiquimod 5% cream in the treatment of external genital warts in women.

International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics·2002
Same author

Imiquimod, a patient-applied immune-response modifier for treatment of external genital warts.

Antimicrobial agents and chemotherapy·1998
Same author

Diagnosis of human papillomavirus genital tract infection.

The American journal of medicine·1997
Same author

D-dimer test for early detection of HELLP syndrome.

Southern medical journal·1995
Same author

Effect of preinduction cervical softening with dinoprostone gel on outcome of oxytocin-induced labor.

Clinical therapeutics·1993
Same author

Detection of fibrin D-dimer in plasma and urine of pregnant women using Dimertest latex assay.

Southern medical journal·1993

Area of Science:

  • Immunology
  • Dermatology
  • Virology

Background:

  • Imiquimod is an immune response modifier.
  • It stimulates interferon-alpha and cytokine production.
  • Genital warts are caused by human papilloma virus (HPV).

Purpose of the Study:

  • To review pivotal studies on imiquimod for HPV infections.
  • To confirm the efficacy of imiquimod 5% cream.
  • To compare imiquimod creams with a vehicle cream.

Main Methods:

  • Review of two multi-center studies.
  • Comparison of imiquimod 1% cream, imiquimod 5% cream, and vehicle cream.
  • Treatment involved overnight application, three times weekly.

Main Results:

  • Imiquimod 5% cream demonstrated significant efficacy in treating external anogenital warts.
  • Lower recurrence rates were observed with imiquimod compared to other treatments.
  • Both imiquimod concentrations showed effectiveness, with safety profiles evaluated.

Conclusions:

  • Imiquimod 5% cream is a promising treatment for external genital and perianal warts.
  • It offers a favorable alternative with reduced recurrence rates for HPV infections.
  • Further confirmation of its efficacy and safety in HPV treatment is supported by the reviewed studies.

Related Experiment Videos